Laurence Whitty-Léveillé, Ph.D

Associate Principal Scientist at Merck & Co

Speaker

Laurence earned her Ph.D. from Université Laval in Québec City, Canada, in 2019, where her dissertation focused on the development of metal extraction methodologies utilizing ligand immobilization on magnetic nanoparticles. In 2020, she joined Merck, leveraging her extensive expertise in metal analysis and proficiency in quantitation to collaborate on a diverse array of programs as a metal expert. In 2022, she pioneered a novel approach to investigate the interactions between metals present in stainless steel and antibodies across various formulations within the industry. This experience ignited her interest in expanding her skill set to include antibody mass spectrometry, contributing to several initiatives, including Clesrovimab, a vaccine designed to immunize children against respiratory syncytial virus (RSV).